Outside of court, Glassman launched World War III against his wife and Anthos Capital. Glassman focused on one point: Anthos would kill CrossFit's spirit, transforming it into a franchise as regimented and conservative as McDonald's. Berger wrote a rallying cry that was originally posted on an internal CrossFit Facebook page and then went wider: "If Anthos gets ownership and forces Greg out, the affiliates can tell Anthos to go f-- off and all de-affiliate in mass....If every single one of you can get 5 people to care about this enough to write Anthos a 'f-- you' email, they will get the picture very quickly."Employees called affiliates around the clock to ask if they had questions and educate them about Anthos's true intentions as CrossFit saw them. When Anthos partner Bryan Kelly offered to field affiliate questions on Lauren's Facebook page, the Russes assaulted him with pointed questions.

The WHO trial (so named because the international team of principal investigators contained World Health Organization members) tested the potential of clofibrate, a “pre-statin” cholesterol-lowering agent, to reduce heart attack morbidity and mortality. The investigators ultimately concluded that clofibrate "cannot be recommended as a lipid-lowering drug for community-wide primary prevention of ischaemic heart disease.” Nevertheless, clofibrate remained in use until 2002, when it was pulled for increasing cancer rates. In their review of studies such as the WHO trial, Uffe Ravnskov and David Diamond observe, “Despite the largely disappointing findings from 50 years of cholesterol lower[ing] trials, the indictment and conviction of cholesterol as the causal agent in CVD [cardiovascular disease] has stood the test of time. … [Yet] the grand effort to reduce cholesterol as a strategy to improve health has failed.”
×